
The Executive Director, IT R&D will oversee an IT organization that drives the standard and compliant delivery of IT R&D support and services. Key objectives for this role will be to establish technology delivery standards for the R&D function based on business need. The role will be responsible to plan, direct, and manage the IT solutions for Clinical, Drug Safety, Regulatory, Medical Affairs and the Research and Development areas within Alkermes and provide leadership and knowledge empowerment for team members and mature the IT R&D services within the company.
This role will be a key member of the IT Senior Leadership Team and will be the primary liaison between various internal and external IT organizations and the previously mentioned Alkermes functional areas. This position will report to the Chief Information Officer (CIO).
This role will work a weekly hybrid office schedule in our Waltham location.
Basic Qualifications/Minimum Education & Experience Requirements:
Preferred Qualifications/Personal Attributes:
The annual base salary for this position ranges from $275,000 to $310,000. In addition, this position is eligible for an annual performance pay bonus. Exact compensation may vary based on skills, training, knowledge, and experience. Alkermes offers a competitive benefits package. Additional details can be found on our careers website: www.alkermes.com/careers#working-here
#LI-TS1

At Alkermes, we apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized.
Our greatest strengths at Alkermes are our people and our inherent empathy for patients, families and caregivers. Neurological and psychiatric disorders strike people at the core of who they are and impact many facets of their lives. We work with urgency to develop new treatment options for people living with these conditions.
Beyond our important mission of developing medicines, we believe it is our responsibility to take a holistic approach as we seek to support patients, caregivers and broader impacted communities. We remain committed to patient engagement, responsible and sustainable operations, and equitable access to quality treatment.
Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio.
See our Community Guidelines: https://www.alkermes.com/social-community-guidelines